Towards uncertainty quantification of a model for cancer-on-chip experiments

📅 2026-02-05
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
This study addresses the challenge of predictive reliability in cancer-on-chip experiments arising from parameter uncertainty by employing a Keller–Segel-type chemotaxis model to describe interactions between cancer and white blood cells. The work introduces an integrated computational framework that innovatively combines global sensitivity analysis (via Sobol and Morris methods), Bayesian inversion, forward uncertainty propagation, and a sparse grid surrogate model, with efficient numerical solution of the underlying partial differential equations achieved through a hybrid discontinuous Galerkin method. This approach substantially enhances computational efficiency, successfully identifies influential parameters, yields data-driven posterior parameter distributions, and quantifies the impact of residual parameter uncertainty on model outputs, thereby providing a robust theoretical foundation for reliable prediction and control in cancer-on-chip experimentation.

Technology Category

Application Category

📝 Abstract
This study is a first step towards using data-informed differential models to predict and control the dynamics of cancer-on-chip experiments. We consider a conceptualized one-dimensional device, containing a cancer and a population of white blood cells. The interaction between the cancer and the population of cells is modeled by a chemotaxis model inspired by Keller-Segel-type equations, which is solved by a Hybridized Discontinuous Galerkin method. Our goal is using (synthetic) data to tune the parameters of the governing equations and to assess the uncertainty on the predictions of the dynamics due to the residual uncertainty on the parameters remaining after the tuning procedure. To this end, we apply techniques from uncertainty quantification for parametric differential models. We first perform a global sensitivity analysis using both Sobol and Morris indices to assess how parameter uncertainty impacts model predictions, and fix the value of parameters with negligible impact. Subsequently, we conduct an inverse uncertainty quantification analysis by Bayesian techniques to compute a data-informed probability distribution of the remaining model parameters. Finally, we carry out a forward uncertainty quantification analysis to compute the impact of the updated (residual) parametric uncertainties on the quantities of interest of the model. The whole procedure is sped up by using surrogate models, based on sparse-grids, to approximate the mapping of the uncertain parameters to the quantities of interest.
Problem

Research questions and friction points this paper is trying to address.

uncertainty quantification
cancer-on-chip
parameter uncertainty
model prediction
differential models
Innovation

Methods, ideas, or system contributions that make the work stand out.

uncertainty quantification
cancer-on-chip
Hybridized Discontinuous Galerkin
Bayesian inverse problem
surrogate modeling
🔎 Similar Papers
No similar papers found.
Silvia Bertoluzza
Silvia Bertoluzza
CNR - IMATI "Enrico Magenes"
V
Vittoria Bianchi
Università degli Studi di Pavia, Via Ferrata 5, 27100, Pavia, Italy
G
Gabriella Bretti
Consiglio Nazionale delle Ricerche – Istituto di Applicazioni del Calcolo, Via dei Taurini 19, 00185, Rome, Italy
Lorenzo Tamellini
Lorenzo Tamellini
CNR-IMATI
Uncertainty Quantification
P
Pietro Zanotti
Università degli Studi di Milano – Dipartimento di Matematica, Via Saldini 50, 20133, Milano, Italy